Diagnostic accuracy of contrast-enhanced CT versus PET/CT for advanced ovarian cancer staging: a comparative systematic review and meta-analysis
- 25 March 2024
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (6) , 2135-2144
Abstract
Purpose Accurate staging of ovarian cancer is critical to guide optimal management pathways. North American guidelines recommend contrast-enhanced CT as the primary work-up for staging ovarian cancer. This meta-analysis aims to compare the diagnostic accuracy of contrast-enhanced CT alone to PET/CT for detecting abdominal metastases in patients with a new or suspected diagnosis of ovarian cancer. Materials and methods A systematic review of MEDLINE, EMBASE, Scopus, the Cochrane Library, and the gray literature from inception to October 2022 was performed. Studies with a minimum of 5 patients evaluating the diagnostic accuracy of contrast-enhanced CT and/or PET/CT for detecting stage 3 ovarian cancer as defined by a surgical/histopathological reference standard ± clinical follow-up were included. Study, clinical, imaging, and accuracy data for eligible studies were independently acquired by two reviewers. Primary meta-analysis was performed in studies reporting accuracy on a per-patient basis using a bivariate mixed-effects regression model. Risk of bias was evaluated using QUADAS-2. Results From 3701 citations, 15 studies (918 patients with mean age ranging from 51 to 65 years) were included in the systematic review. Twelve studies evaluated contrast-enhanced CT (6 using a per-patient assessment and 6 using a per-region assessment) and 11 studies evaluated PET/CT (7 using a per-patient assessment and 4 using a per-region assessment). All but one reporting study used consensus reading. Respective sensitivity and specificity values on a per-patient basis were 82% (67–91%, 95% CI) and 72% (59–82%) for contrast-enhanced CT and 87% (75–94%) and 90% (82–95%) for PET/CT. There was no significant difference in sensitivities between modalities (p = 0.29), but PET/CT was significantly more specific than CT (p < 0.01). Presumed variability could not be assessed in any single category due to limited studies using per-patient assessment. Studies were almost entirely low risk for bias and applicability concerns using QUADAS-2. Conclusion Contrast-enhanced CT demonstrates non-inferior sensitivity compared to PET/CT, although PET/CT may still serve as an alternative and/or supplement to CT alone prior to and/or in lieu of diagnostic laparoscopy in patients with ovarian cancer. Future revisions to existing guidelines should consider these results to further refine the individualized pretherapeutic diagnostic pathway.Keywords
This publication has 28 references indexed in Scilit:
- [68Ga]Ga-FAPI-04 PET/CT in the evaluation of epithelial ovarian cancer: comparison with [18F]F-FDG PET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2023
- Best practices for MRI systematic reviews and meta‐analysesJournal of Magnetic Resonance Imaging, 2018
- Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy StudiesJAMA, 2018
- Treatment of multiple test readers in diagnostic accuracy systematic reviews-meta-analyses of imaging studiesEuropean Journal of Radiology, 2017
- Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancerCochrane Database of Systematic Reviews, 2014
- FDG-PET/CT in advanced ovarian cancer staging: Value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopyEuropean Journal of Radiology, 2011
- Region-based diagnostic performance of multidetector CT for detecting peritoneal seeding in ovarian cancer patientsArchives of Gynecology and Obstetrics, 2010
- Diagnosis and staging of primary ovarian cancer: Correlation between PET/CT, Doppler US, and CT or MRIGynecologic Oncology, 2010
- An evidence-based practice guideline for the peer review of electronic search strategiesJournal of Clinical Epidemiology, 2009
- Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008